Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Intel Trader who wrote (4810)	7/7/1998 4:49:00 PM
From: Peter Singleton	Respond to of 6136

OT yeah, IT, dead on ... I still believe you can tell the good guys by the color of their hats, and if I lost a tooth, I'd put it under the pillow and expect a buck the next morning. I can't help it ... you're right, the guys with the big $ know how to play this game ...

To: Intel Trader who wrote (4810)	7/7/1998 7:15:00 PM
From: Steve Fancy	Read Replies (2) \| Respond to of 6136

Intel, could be, but I think at 23 there just were not any more sellers...the stock was significantly oversold. Bargain hunters came in once they were convinced the massacre was over. Despite my concerns, I believe the company is worth 28-35 until we see further clarification on pending issues. I hope to see Ms Wang come back down to earth with her price target tomorrow. Shouldn't hurt the stock and may start rebuilding her credibility as far as AGPH anyway. I hope we can resolve this AG3340 issue one way or the other soon. I personally don't think this is helping, and obviously the street is not overwhelmed with current information either. If we could either can this project, or offer some convincing reason why the project is continuing, I think it may offer a lot more credibility to the 3 new HIV deals. sf